ChargePoint Holdings, Inc. CHPT 深 滬
等待開盤 01-28 09:30:00 美东时间
6.49
-0.070
-1.07%
華盛通- 最 高6.62
- 今 開6.56
- 成交量 45.14万股
- 最 低 6.37
- 昨 收 6.56
- 總市值 1.54亿
- 52周最高 17.78
- 市盈率 靜 --
- 換手率 1.91%
- 52周最低 6.37
- 委 比 66.67%
- 總股本 2365.31万
- 歷史最高 989.60
- 量 比 0.64
- 振 幅 3.81%
- 歷史最低 0.00
- 每 手 1
- 風險率 2.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Top Stocks Under $10 that You Can Invest in
Looking for cheap stocks? Stocks priced under $10 can appeal to investors looking to for low-cost investment opportunities. Here's our list of the best cheap stocks right now. We have also provided investment insights and fundamental analysis of them.
01-14 09:56
How Is The Market Feeling About ChargePoint Holdings Inc?
ChargePoint Holdings Inc's (NYSE:CHPT) short interest as a percent of float has...
2025-12-26 04:00
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
UBS Maintains Neutral on ChargePoint Hldgs, Lowers Price Target to $9
UBS analyst Jon Windham maintains ChargePoint Hldgs (NYSE:CHPT) with a Neutral and lowers the price target from $12 to $9.
2025-12-22 22:02
ChargePoint Holdings Stock Slides as Dilution Fears Grow
ChargePoint Holdings ( ($CHPT) ) has fallen by -7.46%. Read on to learn why. Ch...
2025-12-20 22:01
ChargePoint Holdings Faces Stock Turmoil Amid Share Sale
ChargePoint Holdings ( ($CHPT) ) has fallen by -8.84%. Read on to learn why. Ch...
2025-12-13 22:01
ChargePoint Files For Offer, Resale From Time To Time By Selling Securityholders Of Up To 4.7M Shares
ChargePoint Holdings, Inc.Up to 4,728,252 Shares of Common Stock This prospectus relates to the offer and resale from time to time by the selling securityholders named in this prospectus or their
2025-12-13 05:44
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
